Search with one or more keywords

This page gives you access to all the studies carried out by French researchers, identified on Covid-19.

To view other resources related to Covid-19, click here.

xml
XML

Export to XML

Please choose the format :

XML
XML-DDI
pdf
PDF

Export to PDF

Which version do you want to export ?

Download full content
Download light content
csv
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection
Export to CSV

ARCHIVES : 309 forms

Sorting of results :

PERFECTA - Intravenous analgesics for post-operative pain: patterns of use in high-risk populations

Head : Boccard Éric, Bristol-Myers Squibb
Schmidely Nathalie, Bristol-Myers Squibb

Version 1
Voir
View
Overview

19

Last update : 01/01/2018

ARCHIVE

PERFECTA - Intravenous analgesics for post-operative pain: patterns of use in high-risk populations

Head : Boccard Éric, Bristol-Myers Squibb
Schmidely Nathalie, Bristol-Myers Squibb

Main objective

Describe the post-chirurgical drug treatment for pain after a surgical intervention, in target groups of patients having specific risks of developing complications during the use of certain classes of analgesics

Inclusion criteria

M/F patients, >=18 years, have an ASA score of level 3 or 4 and having undergone a surgical intervention, including coeloscopy, excluding cardiac surgery and neurosurgery, requiring antalgic treatment through IV in order to relieve postoperative pain.
Patients having at least one of the following risk factors: aged ≥ 65 years, OCPD including sleep apnea, high blood pressure, kidney, heart or liver failure.

Last update : 01/01/2018

Voir
View

PPGP - Paris Prevention in General Practice

Head : Rigal Laurent, Inserm U1018 - Centre de Recherche en Épidémiologie et Santé des Populations Team: Genre, Santé sexuelle et Reproductive

Version 1
Voir
View
Overview

20

Last update : 10/20/2017

ARCHIVE

PPGP - Paris Prevention in General Practice

Head : Rigal Laurent, Inserm U1018 - Centre de Recherche en Épidémiologie et Santé des Populations Team: Genre, Santé sexuelle et Reproductive

Main objective

To analyse social inequalities in preventive practices in general medicine.

Inclusion criteria

- hommes entre 35 et 64 ans pour la consommation de tabac et d’alcool
- femmes entre 50 et 69 ans pour le dépistage des cancers gynécologiques

Last update : 10/20/2017

Voir
View

PHOENIX - Cohort on the scalable process of post traumatic stress disorders : The involvement of stress regulation systems and the role of allostatic load

Head : Chaudieu Isabelle, Inserm U1061

Version 1
Voir
View
Overview

21

Last update : 06/01/2020

ARCHIVE

PHOENIX - Cohort on the scalable process of post traumatic stress disorders : The involvement of stress regulation systems and the role of allostatic load

Head : Chaudieu Isabelle, Inserm U1061

Main objective

The main goal of the project is to study the psychological consequences of violent trauma and the predictive value of biological and clinical stress markers in the development of PTSD
The specific objectives are :
1) To evaluate the allostatic load level and its development over time
2) To evaluate the prevalence of PTSD and other psychiatric co-morbidities (as depression) on subjects who did endure severe events
3) To determine if the allostatic load level is in link with a chronical development of a post traumatic stress disorder

Inclusion criteria

-women and men aged 18 to 75 years
-person who have experienced a traumatic event during the previous week (0 to 7 days before)
-type of events : physical assault, sexual assault, work accident, road accident, natural disaster.

Last update : 06/01/2020

Voir
View

"AZF" Santé Cohort - Cohort of Toulouse Conurbation Workers

Head : Buisson Catherine, DÉPARTEMENT SANTÉ TRAVAIL (DST)
Diène Eloi, Département santé travailInstitut de veille sanitaire94415 Saint Maurice Cedex

Version 1
Voir
View
Overview

22

Last update : 12/01/2019

ARCHIVE

"AZF" Santé Cohort - Cohort of Toulouse Conurbation Workers

Head : Buisson Catherine, DÉPARTEMENT SANTÉ TRAVAIL (DST)
Diène Eloi, Département santé travailInstitut de veille sanitaire94415 Saint Maurice Cedex

Main objective

General objectives:
- To investigate the medium-term health effects from the explosion at the AZF plant that occurred in September 2001 in the population of workers;
- To test access procedures for medical-administrative data (ERASMUS) for monitoring large prospective cohorts.

Inclusion criteria

Working within the Toulouse conurbation and agreeing to participate in the cohort during the cross-sectional study, carried out between September 2002 and April 2003.

Last update : 12/01/2019

Voir
View

SU.FOL.OM3 - SU.FOL.OM3 Trial: B-vitamins and N-3 polyunsaturated fatty acids supplementation and risk of recurrence of cardiovascular events

Head : Hercberg Serge, Unité de Recherche en Epidémiologie Nutritionnelle (UREN), U557 Inserm / U1125 Inra / Cnam / Université Paris 13 (Sorbonne Paris-Cité)
Galan Pilar, Unité de Recherche en EPidémiologie Nutritionnele (UREN), U557 Inserm / U1125 Inra / Cnam / Université Paris 13 (Sorbonne Paris-Cité)

Version 3
Voir
View
Overview

23

Last update : 01/01/2020

ARCHIVE

SU.FOL.OM3 - SU.FOL.OM3 Trial: B-vitamins and N-3 polyunsaturated fatty acids supplementation and risk of recurrence of cardiovascular events

Head : Hercberg Serge, Unité de Recherche en Epidémiologie Nutritionnelle (UREN), U557 Inserm / U1125 Inra / Cnam / Université Paris 13 (Sorbonne Paris-Cité)
Galan Pilar, Unité de Recherche en EPidémiologie Nutritionnele (UREN), U557 Inserm / U1125 Inra / Cnam / Université Paris 13 (Sorbonne Paris-Cité)

Main objective

Primary objectives: check the impact of folate (and vitamin B6 or B12) and/or omega 3 supplements in preventing the recurrence of ischemic disorders in patients with a background of ischemic cardio or cerebrovascular history.

Secondary objective: assess the role of certain genetic mutations in the ability of supplements to reduce the risk of cardiovascular diseases.

Inclusion criteria

Subjects aged between 45 and 80, having presented a myocardial infarction, unstable angina or stroke in the period preceding their inclusion (event occurred at least one month and at the most one year prior to inclusion).

Exclusion criterion: subjects that have to take B12, folic acid or B6 supplements, subjects under methotrexate treatment, subjects suffering from a life-threatening non-cardiovascular disease over the 5 years of the study, severe chronic kidney disease sufferers.

Last update : 01/01/2020

Voir
View

COLCHIC - Assessment of chemotherapy practices in patients with colorectal cancer at the Bordeaux University Hospital

Head : Fourrier-Reglat Annie, Service de Pharmacologie, CIC-P 0005-INSERM U657- Université Bordeaux Segalen
Moore Nicholas, Service de Pharmacologie, CIC-P 0005-INSERM U657- Université Bordeaux Segalen

Version 3
Voir
View
Overview

24

Last update : 01/01/2018

ARCHIVE

COLCHIC - Assessment of chemotherapy practices in patients with colorectal cancer at the Bordeaux University Hospital

Head : Fourrier-Reglat Annie, Service de Pharmacologie, CIC-P 0005-INSERM U657- Université Bordeaux Segalen
Moore Nicholas, Service de Pharmacologie, CIC-P 0005-INSERM U657- Université Bordeaux Segalen

Main objective

The main objective was to evaluate the conditions of use and monitoring of chemotherapy for the treatment of colorectal cancer clinical departments at the University Hospital of Bordeaux, and to assess the appropriateness of prescribing practices in relation to current official recommendations.

Inclusion criteria

Patient with colon or rectal cancer treated with chemotherapy between 1 March 2005 and 1 March 2006; Patient followed at the Bordeaux University Hospital; Patient not objecting to the data collection.

Last update : 01/01/2018

Voir
View

Please wait...

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here